rucaparib
clovis
['gyn', 'platinum', 'brca', 'rucaparib', 'ovarian']
patients with relapsed ovarian cancer with deleterious brca1/2 mutation and who were sensitive to platinum-based therapy showed better pfs and similar rates of os when given rucaparib vs chemotherapy. #esmo2022 #gyncsm | 
Oncology news and insights from leading researchers and cancer centers.